Method of treating diseases that respond to therapy by dopamine or dopamine agonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9108900
APP PUB NO 20140051768A1
SERIAL NO

14063821

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a medicament containing (S)-2-N-propylamino-5-hydroxytetralin, the salts or prodrugs thereof. As a D3 agonist, (S)-2-N-propylamino-5-hydroxytetralin is suitable particularly for the treatment of dopa-sensitive movement disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UCB PHARMA GMBHALFRED-NOBEL-STRASSE 10 MONHEIM 40789

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hansen, Klaus Grevenbroich-Münchrath, DE 4 54
Scheller, Dieter Neuss, DE 12 308

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 18, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00